<DOC>
	<DOC>NCT01903148</DOC>
	<brief_summary>The purpose of this study is to evaluate the impact of the last recommendations of the European Anemia Working Group ERBP in the anemia management in the achievement of the therapeutic goal of Hb 11-12 g/dL.</brief_summary>
	<brief_title>Anemia Management in Chronic Kidney Disease Not on Dialysis Patients After the European Renal Best Practice (ERBP) Working Group Recommendations</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<criteria>Adults patients with anemia secondary to chronic kidney disease (CKD) not on dialysis. Patients starting anemia treatment (na√Øve) after six months of the last recommendations of the European Anemia Working Group ERBP (January 2011). Patients in treatment who changed from previous ESA treatment since January 2011 (converted patients Patients in Erythropoiesis Stimulating Agents (ESA) dose adjustment period. Kidney transplant patients.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>ANEMIA IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS</keyword>
</DOC>